Stephanie Berg

GU medical oncologist at Dana-Farber Cancer Institute with expertise in prostate and bladder cancer clinical trials and precision oncology, featured as the episode's expert guest.

Best podcasts with Stephanie Berg

Ranked by the Snipd community

Oct 23, 2025 • 23min

GU Cancer ESMO 2025 Highlights: PSMAddition, Capitello-281, Potomac, Keynote-905, IMVigor011

Dr. Stephanie Berg, a GU medical oncologist from Dana-Farber Cancer Institute, shares insights on groundbreaking cancer studies presented at ESMO 2025. She discusses the promising impact of lutetium PSMA in prostate cancer and highlights the effectiveness of capivasertib for patients with PTEN loss. The conversation also touches on the combination of durvalumab and BCG for high-risk bladder cancer, alongside innovative ctDNA-guided therapies improving survival rates. Tune in for a deep dive into the complexities of cancer treatment and patient-centered care!

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app